Skip to main content
. 2020 Nov 2;35(1):33–42. doi: 10.1111/jvim.15948

TABLE 3.

Geometric mean (95% confidence interval) of plasma equilibrium concentrations of angiotensin peptides (APs) and mean (SD) measures of surrogate markers of plasma renin activity (PRA‐S) and angiotensin converting enzyme (ACE‐S) and ratio of alternative to traditional APs (ALT : TRAD) in 6 cats with cardiomyopathy while receiving no renin‐angiotensin‐aldosterone system inhibiting drugs (no RAASi), while receiving angiotensin receptor blocker (ARB), and after in vitro incubation of plasma with recombinant human angiotensin converting enzyme‐2 (rhACE2)

No RAASi (A) ARB (B) No RAASi + ACE2 (C) ARB + ACE2 (D) P value
AT1 (pg/mL) 61 276 44 194 .003
(19‐202) (86‐891) (16‐118) (56‐678) A vs B, P = .02
A vs C, P = .04
C vs D, P = .02
B vs D, P = .01
AT2 (pg/mL) 199 913 <LLOD a <LLOD a <.001
(73‐539) (282‐2955) A vs B, P = .003
A vs C, P < .001
B vs D, P < .001
Ang1‐9 (pg/mL) <LLOD b <LLOD b 4.6 18 .02
(1.5‐12.1) (3.3‐99) C vs D, P = .04
B vs D, P = .04
Ang1‐7 (pg/mL) 30 147 29 159 .001
(10.4‐87) (43‐508) (7.1‐122) (47‐539) A vs B, P = .01
C vs D, P = .01
Ang1‐5 (pg/mL) 195 552 283 800 .02
(80‐474) (148‐2064) (106‐754) (253‐2528) A vs C, P = .004
AT3 10 47 NA NA .67
(2.6‐41) (12‐186)
AT4 3.7 20 NA NA .48
(1.1‐12) (5.5‐73)
PRA‐S 375 1879 61 321 <.001
(331) (1772) (46) (303) A vs B, P = .007
A vs C, P < .001
C vs D, P = .007
B vs D, P < .001
ACE‐S 3.4 3.3 0.034 0.009 <.001
(1.0) (0.3) (0.033) (0.010) A vs C, P < .001
B vs D, P < .001
ALT : TRAD 0.88 0.62 7.1 6.1 <.001
(0.13) (0.20) (1.4) (2.6) A vs C, P < .001
B vs D, P = .005

Abbreviations: Ang1‐5, angiotensin 1‐5; Ang1‐7, angiotensin 1‐7; Ang1‐9, angiotensin 1‐9; AT1, angiotensin 1; AT2, angiotensin 2; AT3, angiotensin 3; AT4, angiotensin 4; LLOD, lower limit of detection.

a

All values less than the lower limit of detection, 2.0 pg/mL.

b

All values less than the lower limit of detection, 3.5 pg/mL.